CD4 and hematologic disorder: On the other hand, the proportions of patients among HDs with sufficient SARS-CoV-2 specific T-cells above the cut-off value painted a different picture: CD4 T-cell responses in patients with hematological diseases were reduced, and CD8 T-cell responses were sustained or even elevated in all vaccine group compared to healthy controls.